Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma

Clinical trial NCT02145715 · UNKNOWN

Trial details

NCT number: NCT02145715
Sponsor: Prof Jamie Cavenagh
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2013-01-01
Primary completion: 2015-07-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.